Publications by authors named "Hiroshi Inooka"

Claim this Profile
H
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications.
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, Ryo Aoki, Masahiro Ishikane, Hiroshi Inooka

Gastroenterology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.
Hiroaki Nagai, Tomoko Kaisho, Kotaro Yokoyama, Tomoko Asakawa, Hisashi Fujita, Hiroshi Inooka

Br J Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.
Takeshi Yasui, Takeshi Yamamoto, Nozomu Sakai, Kouhei Asano, Takafumi Takai, Hiroshi Inooka

Bioorg Med Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology.
Kotaro Sakamoto, Yoko Kanematsu-Yamaki, Yusuke Kamada, Masahiro Oka, Toshiyuki Ohnishi, Hiroshi Inooka

Biochem Biophys Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration.
Yasushi Masuda, Satoshi Kumano, Jiro Noguchi, Kotaro Sakamoto, Hiroshi Inooka

Peptides· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.
Yoko Kanematsu-Yamaki, Naoki Nishizawa, Tomoko Kaisho, Hiroaki Nagai, Taisuke Mochida, Hiroshi Inooka

J Med Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.
Hiroshi Inooka, Kotaro Sakamoto, Tokuyuki Shinohara, Yasushi Masuda, Michiko Terada

Bioorg Med Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries.
Toshiyuki Ohnishi, Kotaro Sakamoto, Asano Asami-Odaka, Kimie Nakamura, Ayako Shimizu, Hiroshi Inooka

Biochem Biophys Res Commun· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.
Kotaro Sakamoto, Yayoi Kawata, Yasushi Masuda, Tadashi Umemoto, Takashi Ito, Hiroshi Inooka

Biochem Biophys Res Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Conformation of a peptide ligand bound to its G-protein coupled receptor and its implication for ligand transportation].
Hiroshi Inooka, Masahiro Shirakawa

Tanpakushitsu Kakusan Koso· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis